Skip to search formSkip to main contentSkip to account menu

BRL 36650

Known as: BRL-36650 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

foramidocillin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
Structure-activity relationships of some arylglycine analogues and catechol isosteres of BRL 36650, a 6 alpha-formamido penicillin.
The catecholic acylureido derivative BRL 36650 was the most potent, especially against Pseudomonas aeruginosa strains. We now… 
1986
1986
In vitro susceptibility of Citrobacter species to various antimicrobial agents
The in vitro activities of 16 antimicrobial agents against 14 clinical isolates of Citrobacter diversus and 27 isolates of… 
1986
1986
In vitro activity of BRL 36650, a new semisynthetic penicillin
BRL 36650 [sodium 6 beta-(D-2-[(4-ethyl-2, 3-dioxopiperazin-1-yl)carbonylamino]-2-(3,4-dihydroxyphenyl) acetamido)-6 alpha… 
1986
1986
In vitro activity of BRL 36650, a new penicillin
Compared with four beta-lactam antibiotics and amikacin, BRL 36650 and BMY-28142 were the most active against 509… 
1986
1986
BRL-36650: in vitro studies and assessment of serum bactericidal activity after single-dose administration in volunteers
Ten healthy volunteers received 1 g of BRL-36650, a new formamido-penicillin derivative, given by intravenous infusion over 15… 
1986
1986
In-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin, against multiply resistant gram-negative organisms.
The in-vitro activity of BRL-36650, a novel beta-lactamase-stable penicillin was tested in comparison with that of cefotaxime… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)